Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tailored Smoking Cessation Treatment for LIVE FOR LIFE Participants
NCT01560507Phase 3Terminated
- Sponsor
- Duke University
- Start
- May 2012
- Primary completion
- Jul 2013
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline + nicotine patch, bupropion, nicotine patch in nicotine dependence, Tobacco Use Disorder (TUD), sponsored by Duke University. Started May 2012; status: terminated.
02
Drugs
varenicline + nicotine patchbupropionnicotine patch
03
Conditions
nicotine dependenceTobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT01560507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01560507.